HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figures All Versions of this Article: 296/2/E228    most recent 90347.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Natalicchio, A. Articles by Giorgino, F. Search for Related Content PubMed PubMed Citation Articles by Natalicchio, A. Articles by Giorgino, F.

Involvement of the p66^Shc protein in glucose transport regulation in skeletal muscle myoblasts

Department of Emergency and Organ Transplantation, Section on Internal Medicine, Endocrinology and Metabolic Diseases, University of Bari, Bari, Italy

Submitted 27 June 2008 ; accepted in final form 15 October 2008

The p66^Shc protein isoform regulates MAP kinase activity and the actin cytoskeleton turnover, which are both required for normal glucose transport responses. To investigate the role of p66^Shc in glucose transport regulation in skeletal muscle cells, L6 myoblasts with antisense-mediated reduction (L6/p66^Shcas) or adenovirus-mediated overexpression (L6/p66^Shcadv) of the p66^Shc protein were examined. L6/^Shcas myoblasts showed constitutive activation of ERK-1/2 and disruption of the actin network, associated with an 11-fold increase in basal glucose transport. GLUT1 and GLUT3 transporter proteins were sevenfold and fourfold more abundant, respectively, and were localized throughout the cytoplasm. Conversely, in L6 myoblasts overexpressing p66^Shc, basal glucose uptake rates were reduced by 30% in parallel with a 50% reduction in total GLUT1 and GLUT3 transporter levels. Inhibition of the increased ERK-1/2 activity with PD98059 in L6/^Shcas cells had a minimal effect on increased GLUT1 and GLUT3 protein levels, but restored the actin cytoskeleton, and reduced the abnormally high basal glucose uptake by 70%. In conclusion, p66^Shc appears to regulate the glucose transport system in skeletal muscle myoblasts by controlling, via MAP kinase, the integrity of the actin cytoskeleton and by modulating cellular expression of GLUT1 and GLUT3 transporter proteins via ERK-independent pathways.

glucose transporter 1; glucose transporter 3; extracellular signal related kinase

This article has been cited by other articles:

				J. Sainz and M. Sata When p66ShcA is away, mice EPCs sweetly play Cardiovasc Res, June 1, 2009; 82(3): 388 - 389. [Full Text] [PDF]